Archive | Novo Nordisk Pharmatech A/S

Home / Archive

Novo Nordisk Pharmatech showcasing recombinant insulin advantages at Bioprocessing 2019 Boston

Monday 29th July 2019

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showcasing human insulin-based production advances at ESACT Copenhagen

Thursday 2nd May 2019

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech brings recombinant insulin advances to BIOProcess International Europe

Wednesday 20th March 2019

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showing recombinant insulin advances at BPI West in California

Thursday 28th February 2019

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showing recombinant insulin advances at Annual Biologics Manufacturing Asia

Tuesday 12th February 2019

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for eleven markets in Asia Pacific

Wednesday 16th January 2019

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech highlighting its cGMP FEF® Quats at CPhI Madrid

Tuesday 25th September 2018

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech and Signet Chemical Corporation enter a distribution agreement for cGMP Quaternary Ammonium Compounds

Thursday 16th August 2018

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showing power of recombinant insulin human at Bioprocessing Summit Boston

Wednesday 25th July 2018

By Novo Nordisk… Learn More >

How to increase specific influenza production with recombinant human insulin

Thursday 5th July 2018

By Novo Nordisk… Learn More >

Pharmaceutical grade quaternary ammonium compounds

Monday 18th June 2018

By Novo Nordisk… Learn More >

Novo Nordisk Pharmatech showing enhanced recombinant insulin advantages at Biologics Manufacturing Korea

Monday 14th May 2018

By Novo Nordisk… Learn More >